{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:43:33Z","timestamp":1788183813333,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.expneurol.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T12:32:48Z","timestamp":1347885168000},"page":"243-253","source":"Crossref","is-referenced-by-count":45,"title":["Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: A preclinical stroke trial"],"prefix":"10.1016","volume":"238","author":[{"given":"Juraj","family":"Culman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Nguyen-Ngoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Glatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Herdegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2012.09.003_bb0230","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","article-title":"Guidelines for the early management of adults with ischemic stroke","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0235","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2009.03.040","article-title":"Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat","volume":"1271","author":"Allahtavakoli","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0010","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1582-4934.2010.01135.x","article-title":"Neuroprotection in acute ischemic stroke\u2013current status","volume":"14","author":"Auriel","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0020","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/hs1001.098155","article-title":"Early stroke: A dynamic process","volume":"32","author":"Boysen","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.hjh.0000254376.80864.d3","article-title":"Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke","volume":"25","author":"Brdon","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1172\/JCI118041","article-title":"Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect","volume":"96","author":"Buchanan","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0035","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1152\/ajpendo.00424.2003","article-title":"Identification of a novel mitochondrial protein (\"mitoNEET\") cross-linked specifically by a thiazolidinedione photoprobe","volume":"286","author":"Colca","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1753944708090924","article-title":"PPARs as new therapeutic targets for the treatment of cerebral ischemia\/reperfusion injury","volume":"2","author":"Collino","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2007.03.004","article-title":"PPAR-gamma: therapeutic target for ischemic stroke","volume":"28","author":"Culman","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0050","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1074\/jbc.M208132200","article-title":"Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes","volume":"278","author":"Dello Russo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0055","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/sj.jcbfm.9600298","article-title":"Bench to bedside: the quest for quality in experimental stroke research","volume":"26","author":"Dirnagl","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0070","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1161\/STROKEAHA.109.564872","article-title":"Recombinant human erythropoietin in the treatment of acute ischemic stroke","volume":"40","author":"Ehrenreich","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0075","doi-asserted-by":"crossref","first-page":"37006","DOI":"10.1074\/jbc.M700447200","article-title":"Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis","volume":"282","author":"Fuenzalida","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.neuroscience.2010.07.063","article-title":"Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion","volume":"170","author":"Gamboa","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0240","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.STR.26.4.627","article-title":"Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation","volume":"26","author":"Garcia","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuropharm.2007.12.007","article-title":"Neuroprotection for ischemic stroke: past, present and future","volume":"55","author":"Ginsberg","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0245","article-title":"Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC)","author":"Gonzales","year":"2012","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/cm.20455","article-title":"The beta isotypes of tubulin in neuronal differentiation","volume":"67","author":"Guo","year":"2010","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","article-title":"PPARs in the brain","volume":"1771","author":"Heneka","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-6147(97)01157-7","article-title":"To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents?","volume":"19","author":"Hunter","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2009.09.098","article-title":"Pioglitazone enhances pyruvate and lactate oxidation in cultured neurons but not in cultured astroglia","volume":"1305","author":"Izawa","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.expneurol.2008.12.007","article-title":"Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome","volume":"216","author":"Ji","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11064-006-9138-3","article-title":"Effects of thiazolidinediones on stroke recovery: a case-matched controlled study","volume":"32","author":"Lee","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.ATV.0000201933.53964.5b","article-title":"15d-prostaglandin J2 protects brain from ischemia-reperfusion injury","volume":"26","author":"Lin","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6030\/1939-067X-2.2.2","article-title":"Rodent stroke model guidelines for preclinical stroke trials (1st Edition)","volume":"2","author":"Liu","year":"2009","journal-title":"J. Exp. Stroke Transl. Med."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2008.12.028","article-title":"TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion","volume":"179","author":"Liu","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0140","first-page":"29","article-title":"Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys","volume":"47","author":"Maeshiba","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.expneurol.2009.05.026","article-title":"The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI","volume":"218","author":"Mazzeo","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/WCO.0b013e328334e9d9","article-title":"Blood pressure treatment in acute ischemic stroke: a review of studies and recommendations","volume":"23","author":"Ntaios","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0155","doi-asserted-by":"crossref","first-page":"14342","DOI":"10.1073\/pnas.0707189104","article-title":"MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone","volume":"104","author":"Paddock","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcn.2009.07.012","article-title":"The microtubule network and neuronal morphogenesis: Dynamic and coordinated orchestration through multiple players","volume":"43","author":"Poulain","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/jcbfm.2011.197","article-title":"Neurological diseases in relation to the blood\u2013brain barrier","author":"Rosenberg","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0175","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(11)60104-9","article-title":"The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial","volume":"377","author":"Sandset","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0260","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/01.HYP.0000084370.74777.B6","article-title":"Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension","volume":"42","author":"Schiffrin","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.brainres.2004.11.054","article-title":"Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons","volume":"1035","author":"Schmued","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.STR.0000152271.21943.a2","article-title":"A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia","volume":"36","author":"Shimazu","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2012.09.003_bb0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1471-4159.2006.04376.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents","volume":"101","author":"Tureyen","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/j.1460-9568.2006.05037.x","article-title":"Altered PPARgamma expression and activation after transient focal ischemia in rats","volume":"24","author":"Victor","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/jcbfm.2009.87","article-title":"Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats","volume":"29","author":"Wang","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0205","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1471-4159.2010.06999.x","article-title":"Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review","volume":"115","author":"White","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0210","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1096\/fj.05-5007com","article-title":"Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats","volume":"20","author":"Zhao","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0215","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.brainres.2005.12.061","article-title":"Peroxisome-proliferator-activated receptor-gamma (PPARgamma) activation protects neurons from NMDA excitotoxicity","volume":"1073\u20131074","author":"Zhao","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0220","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ana.21097","article-title":"Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia\/macrophages","volume":"61","author":"Zhao","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2012.09.003_bb0225","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2990.2011.01169.x","article-title":"Activation of cerebral peroxisome proliferator-activated receptors \u03b3 (PPAR\u03b3) reduces neuronal damage in the substantia nigra after transient focal cerebral ischaemia in the rat","volume":"37","author":"Zuhayra","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612003548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488612003548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T13:55:50Z","timestamp":1542722150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488612003548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0014488612003548"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2012.09.003","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}